A human vascular endothelial cell model to study angiogenesis and tumorigenesis

被引:47
作者
Rhim, JS [1 ]
Tsai, WP
Chen, ZQ
Chen, Z
Van Waes, C
Burger, AM
Lautenberger, JA
机构
[1] NCI, Lab Biochem Physiol, Frederick, MD 21702 USA
[2] SAIC, IRSP, Lab Cellular Biol, Frederick, MD 21702 USA
[3] NIDOCD, Head & Neck Surg Branch, Bethesda, MD 20892 USA
[4] Univ Freiburg, Tumor Biol Ctr, Freiburg, Germany
[5] NCI, Lab Genom Divers, Frederick, MD 21702 USA
关键词
D O I
10.1093/carcin/19.4.673
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Endothelial cell biology has recently been the subject of considerable interest in thrombosis and cancer research. However, the successful establishment of immortalized human endothelial cells which retain differentiated cell characteristics has been rare. We have successfully established immortalized human umbilical vein endothelial cells (HUVECs) by human papilloma virus (HPV)-16 E6-E7, HPV-16 E6, E7 and E6-E7 were successfully introduced into HUVEC cells. Both E6 and E7 cultures had an extended lifespan but eventually underwent senescence. E6-E7 cultures 4-5-2G, however, acquired an indefinite lifespan in culture but did not undergo malignant conversion. Telomerase activity was not detected in either E6 or E7 cultures; however, telomerase was detected in E6-E7 4-5-2G cells. The cells exhibited a 'cobblestone' morphology and developed a capillary-like tube structure upon reaching confluence. The 4-5-2G line expressed Factor VIII related antigen and took up DiI-Ac-LDL as markers of endothelial origin. The line expressed integrin subunits (alpha v beta 3, alpha v beta 5,beta 1, alpha 2, alpha 3, beta 4 and alpha 6) consistent with an endothelial origin. The higher passage of 4-5-2G line showed a similar intensity of integrin immunostaining to that of primary HUVECS. Subsequent infection of these immortal cells with the Kirsten murine sarcoma virus which contains an activated K-ras oncogene induced morphological transformation that led to the acquisition of invasion capability and neoplastic properties. Telomerase was also detected in the tumorigenic v-Ki-ras transformed cell line. These cell lines should be useful for studies of the molecular mechanisms underlying normal and neoplastic endothelial cell proliferation and migration, and might also provide an in vitro model for development of pharmacologic and gene therapy for cardiovascular thrombosis and cancer.
引用
收藏
页码:673 / 681
页数:9
相关论文
共 60 条
[1]   HMEC-1 - ESTABLISHMENT OF AN IMMORTALIZED HUMAN MICROVASCULAR ENDOTHELIAL-CELL LINE [J].
ADES, EW ;
CANDAL, FJ ;
SWERLICK, RA ;
GEORGE, VG ;
SUMMERS, S ;
BOSSE, DC ;
LAWLEY, TJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (06) :683-690
[2]   ANGIOGENIC PROPERTIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT PROTEIN [J].
ALBINI, A ;
BARILLARI, G ;
BENELLI, R ;
GALLO, RC ;
ENSOLI, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4838-4842
[3]   LOSS OF P53 PROTEIN IN HUMAN PAPILLOMAVIRUS TYPE-16 E6-IMMORTALIZED HUMAN MAMMARY EPITHELIAL-CELLS [J].
BAND, V ;
DECAPRIO, JA ;
DELMOLINO, L ;
KULESA, V ;
SAGER, R .
JOURNAL OF VIROLOGY, 1991, 65 (12) :6671-6676
[4]   TUMOR INTERACTIONS WITH THE VASCULATURE - ANGIOGENESIS AND TUMOR-METASTASIS [J].
BLOOD, CH ;
ZETTER, BR .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1032 (01) :89-118
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[7]   INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].
BROOKS, PC ;
MONTGOMERY, AMP ;
ROSENFELD, M ;
REISFELD, RA ;
HU, TH ;
KLIER, G ;
CHERESH, DA .
CELL, 1994, 79 (07) :1157-1164
[8]   DISTINCT FUNCTIONS FOR INTEGRINS ALPHA-3-BETA-1 IN FOCAL ADHESIONS AND ALPHA-6-BETA-4 BULLOUS PEMPHIGOID ANTIGEN IN A NEW STABLE ANCHORING CONTACT (SAC) OF KERATINOCYTES - RELATION TO HEMIDESMOSOMES [J].
CARTER, WG ;
KAUR, P ;
GIL, SG ;
GAHR, PJ ;
WAYNER, EA .
JOURNAL OF CELL BIOLOGY, 1990, 111 (06) :3141-3154
[9]  
DAMORE PA, 1987, ANNU REV PHYSIOL, V49, P453
[10]  
DICHEK DA, 1993, THROMB HAEMOSTASIS, V70, P198